Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Exogenous Recombinant GCSF in Patients With Repeated Implantation Failure - A Randomized Single-blind Trial

NCT02149277 is registered in ClinicalTrials.gov with Clinique Ovo as lead sponsor.

NCT NCT02149277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02149277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Exogenous Recombinant GCSF in Patients With Repeated Implantation Failure - A Randomized Single-blind Trial
Lead sponsor
Clinique Ovo
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2013
Completion date
December 31, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

repeated embryo implantation failure